Beta bionics announces agreement with abbott to integrate the ilet bionic pancreas with abbott's future dual glucose-ketone sensor

Irvine, calif., june 19, 2025 (globe newswire) -- beta bionics, inc., a pioneering leader in the development of advanced diabetes management solutions, announced its intention to integrate its ilet bionic pancreas automated insulin delivery (aid) system with abbott's future dual glucose-ketone sensor in the u.s.
BBNX Ratings Summary
BBNX Quant Ranking